Vaxfab Statements
54
Data from Vaxfab`s earning releases including common size income statement and balance sheet.
Common size analysis evaluates financial statements by expressing each line item as a percentage of a base amount for that period.
Key Information:
Report currency:
INR - Indian rupee
Last reporting period:
30 Sep, 2023
Next reporting period:
28 Mar, 2024
Report frequency:
Semi-annual
Earnings release date:
—
Expected release date:
—
Vaxfab Income Statement
B
M
INR (except Earnings per share)
Financial
Revenue
Cost of sales
Gross profit
Research and development
Selling, general and administrative
Total operating expenses
Operating income
Interest expense
Other income
Income before tax
Provision for income taxes
Net income
Diluted earnings per share
Shares outstanding after dilution
60.518
-63 %
100
54.222
96.2
6.296
-15.4 %
3.8
—
0
0.149
0.3
3.643
20.1 %
2.9
2.653
-39.9 %
0.9
—
0
1.178
6.2
3.831
-22.8 %
7.1
0.958
1.7
2.873
-24.5 %
5.3
0.34
8.45
163.57
4030.6 %
100
156.12
96.3
7.446
554.3 %
3.7
—
0
0.209
0.1
3.033
190.8 %
1.6
4.413
4545.3 %
2.1
0.548
0.4
—
0
4.961
5292.4 %
2.5
1.158
0.5
3.804
3990.3 %
1.9
4.718
1.532
3.96
45.3 %
100
2.822
73.8
1.138
22860 %
26.2
—
0
0.042
0.8
1.043
-49.5 %
38
0.095
104.6 %
-11.8
-0.003
14.4
—
0
0.092
115.2 %
2.6
—
-0.3
0.093
115.2 %
2.8
0.04
2.192
2.726
—
100
2.731
59.8
-0.005
—
40.2
—
0
0.524
8.8
2.065
234.1 %
49.4
-2.07
-235 %
-9.2
—
0
1.466
24.9
-0.604
-49.9 %
15.6
0.009
0.3
-0.613
-91 %
15.3
-0.259
2.436
—
—
100
—
0
—
—
0
—
0
0.238
0
0.618
—
0
-0.618
—
0
—
0
0.215
0
-0.403
—
0
-0.082
0
-0.321
—
0
-0.23
1.884